PURPOSE: To retrospectively determine the long-term risk of false-positive mammographic assessments and to evaluate the effect of screening regularity on the risk of false-positive events. MATERIALS AND METHODS: Institutional review board approval was obtained, and informed consent was waived. Retrospective analysis was performed for the occurrence of false-positive assessments among 83,511 women who underwent 314,185 mammographic examinations from January 1, 1985, to February 19, 2002. Data were collected from a database that had been assembled prospectively. Two categories of false-positive events were examined: biopsies that did not reveal cancer and false-positive mammographic assessments. Rates of false-positive events were compared by using a chi2 analysis, and 95% confidence limits were calculated. Because comparisons of multiple pairs were considered, all P values that demonstrated statistical significance exceeded the requirement of the Bonferroni correction. RESULTS: While the overall rates of biopsies that did not reveal cancer and of false-positive mammographic assessments were similar to those found in other studies, most of the burden of false-positive events was borne by women who underwent intermittent screening. Long-term rates of false-positive events were lower among women who underwent regular screening than among those who underwent intermittent screening. In the 5-year group, 2.9% of women who underwent five mammographic examinations over the next 5 years had biopsy results that did not reveal cancer, whereas 4.6% of women who underwent three mammographic examinations over the next 5 years had biopsy results that did not reveal cancer. For women who underwent regular screening, the risk of undergoing biopsies that did not reveal cancer declined over time to 0.25% per year after several years of screening, a value that is lower than the risk of these events among women who did not undergo screening. The rate of false-positive mammographic assessments was also lower for women who underwent regular screening than for those who underwent intermittent screening. CONCLUSION: Prompt annual attendance for mammographic screening reduces the occurrence of false-positive mammographic results. RSNA, 2006
PURPOSE: To retrospectively determine the long-term risk of false-positive mammographic assessments and to evaluate the effect of screening regularity on the risk of false-positive events. MATERIALS AND METHODS: Institutional review board approval was obtained, and informed consent was waived. Retrospective analysis was performed for the occurrence of false-positive assessments among 83,511 women who underwent 314,185 mammographic examinations from January 1, 1985, to February 19, 2002. Data were collected from a database that had been assembled prospectively. Two categories of false-positive events were examined: biopsies that did not reveal cancer and false-positive mammographic assessments. Rates of false-positive events were compared by using a chi2 analysis, and 95% confidence limits were calculated. Because comparisons of multiple pairs were considered, all P values that demonstrated statistical significance exceeded the requirement of the Bonferroni correction. RESULTS: While the overall rates of biopsies that did not reveal cancer and of false-positive mammographic assessments were similar to those found in other studies, most of the burden of false-positive events was borne by women who underwent intermittent screening. Long-term rates of false-positive events were lower among women who underwent regular screening than among those who underwent intermittent screening. In the 5-year group, 2.9% of women who underwent five mammographic examinations over the next 5 years had biopsy results that did not reveal cancer, whereas 4.6% of women who underwent three mammographic examinations over the next 5 years had biopsy results that did not reveal cancer. For women who underwent regular screening, the risk of undergoing biopsies that did not reveal cancer declined over time to 0.25% per year after several years of screening, a value that is lower than the risk of these events among women who did not undergo screening. The rate of false-positive mammographic assessments was also lower for women who underwent regular screening than for those who underwent intermittent screening. CONCLUSION: Prompt annual attendance for mammographic screening reduces the occurrence of false-positive mammographic results. RSNA, 2006
Authors: Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti Journal: Ann Intern Med Date: 2011-10-18 Impact factor: 25.391
Authors: Katja Kemp Jacobsen; Linn Abraham; Diana S M Buist; Rebecca A Hubbard; Ellen S O'Meara; Brian L Sprague; Karla Kerlikowske; Ilse Vejborg; My Von Euler-Chelpin; Sisse Helle Njor Journal: Cancer Epidemiol Date: 2015-05-23 Impact factor: 2.984
Authors: Jie Shen; Qiang Hu; Michael Schrauder; Li Yan; Dan Wang; Leonardo Medico; Yuqing Guo; Song Yao; Qianqian Zhu; Biao Liu; Maochun Qin; Matthias W Beckmann; Peter A Fasching; Reiner Strick; Candace S Johnson; Christine B Ambrosone; Hua Zhao; Song Liu Journal: Oncotarget Date: 2014-07-30
Authors: Chris I Flowers; Cristina O'Donoghue; Dan Moore; Adeline Goss; Danny Kim; June-Ho Kim; Sjoerd G Elias; Julia Fridland; Laura J Esserman Journal: Breast Cancer Res Treat Date: 2013-06-14 Impact factor: 4.872